rs41277897
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_058179.4(PSAT1):c.348G>A(p.Lys116Lys) variant causes a synonymous change. The variant allele was found at a frequency of 0.00996 in 1,613,654 control chromosomes in the GnomAD database, including 183 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0092 ( 20 hom., cov: 33)
Exomes 𝑓: 0.010 ( 163 hom. )
Consequence
PSAT1
NM_058179.4 synonymous
NM_058179.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 5.45
Genes affected
PSAT1 (HGNC:19129): (phosphoserine aminotransferase 1) This gene encodes a member of the class-V pyridoxal-phosphate-dependent aminotransferase family. The encoded protein is a phosphoserine aminotransferase and decreased expression may be associated with schizophrenia. Mutations in this gene are also associated with phosphoserine aminotransferase deficiency. Alternative splicing results in multiple transcript variants. Pseudogenes of this gene have been defined on chromosomes 1, 3, and 8. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 9-78304891-G-A is Benign according to our data. Variant chr9-78304891-G-A is described in ClinVar as [Benign]. Clinvar id is 542040.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00922 (1404/152324) while in subpopulation NFE AF= 0.0146 (994/68030). AF 95% confidence interval is 0.0139. There are 20 homozygotes in gnomad4. There are 692 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 20 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PSAT1 | NM_058179.4 | c.348G>A | p.Lys116Lys | synonymous_variant | 4/9 | ENST00000376588.4 | NP_478059.1 | |
PSAT1 | NM_021154.5 | c.348G>A | p.Lys116Lys | synonymous_variant | 4/8 | NP_066977.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PSAT1 | ENST00000376588.4 | c.348G>A | p.Lys116Lys | synonymous_variant | 4/9 | 1 | NM_058179.4 | ENSP00000365773.3 | ||
PSAT1 | ENST00000347159.6 | c.348G>A | p.Lys116Lys | synonymous_variant | 4/8 | 1 | ENSP00000317606.2 |
Frequencies
GnomAD3 genomes AF: 0.00921 AC: 1402AN: 152206Hom.: 20 Cov.: 33
GnomAD3 genomes
AF:
AC:
1402
AN:
152206
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00911 AC: 2292AN: 251476Hom.: 28 AF XY: 0.00900 AC XY: 1223AN XY: 135910
GnomAD3 exomes
AF:
AC:
2292
AN:
251476
Hom.:
AF XY:
AC XY:
1223
AN XY:
135910
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0100 AC: 14667AN: 1461330Hom.: 163 Cov.: 36 AF XY: 0.0101 AC XY: 7346AN XY: 726986
GnomAD4 exome
AF:
AC:
14667
AN:
1461330
Hom.:
Cov.:
36
AF XY:
AC XY:
7346
AN XY:
726986
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00922 AC: 1404AN: 152324Hom.: 20 Cov.: 33 AF XY: 0.00929 AC XY: 692AN XY: 74476
GnomAD4 genome
AF:
AC:
1404
AN:
152324
Hom.:
Cov.:
33
AF XY:
AC XY:
692
AN XY:
74476
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | PSAT1: BS1, BS2 - |
Neu-Laxova syndrome 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: 49
Find out detailed SpliceAI scores and Pangolin per-transcript scores at